physicians must be aware of clinical circumstances that may promote the development of hyperkalemia The renin–angiotensin–aldosterone system (RAAS) has a pathogenetic role in several edematous ...

These investigators claim that the risks of down-titrating or discontinuing RAASi therapy in heart failure patients with moderate hyperkalemia may be overstated. Visit us on Facebook. Opens in a ...